MERS-CoV in South Korea {#cesec10}
=======================

As of June 8, 87 confirmed MERS-CoV infections, including five deaths, have been reported by the South Korean Ministry of Health, in the largest MERS-CoV outbreak outside the Middle East. The first case reported on May 20 was a 68-year-old man who had fallen ill after returning from travelling around several Middle Eastern countries between April 18 and May 3. The patient was asymptomatic on arrival in South Korea but later sought medical care at various facilities; he was admitted to one of these before being diagnosed with MERS-CoV and was then moved to a national treatment facility. The 87 cases reported so far have been from six hospitals in the Gyeonggi Province, four of which were involved in the care of the first case. The cases include health-care professionals, patients, and visitors. So far, contact tracing activities have led to more than 1660 people being isolated. Since the index case, there have been three generations of cases, most of which have been nosocomially transmitted, and most have had known exposure to other laboratory-confirmed cases.

Anthrax in Turkey {#cesec20}
=================

On June 3 and 4, five people were diagnosed with anthrax in the village of Ortakoy in the Black Sea province of Giresun, Turkey. Of these patients, two were sent to Ankara for further tests and treatment. One other person was diagnosed and immediately admitted to hospital. Authorities are undertaking medical examinations of people in the neighbourhood, especially those who have been in contact with animals. The source of the infection remains unknown; however, authorities suspect that straw from outside the province might be the source.

Meningitis in Niger---update {#cesec30}
============================

The meningitis outbreak in Niger continues to gain momentum. Between Jan 1 and April 25, 1543 suspected cases were reported. From April 25 to May 12, this number tripled, bringing the total number of suspected cases from Jan 1 to May 12 to 6179. This is the first large-scale meningitis outbreak caused by *Neisseria meningitidis* serogroup C in a country in Africa\'s meningitis belt, and vaccines against this strain are in short supply. In response, WHO, on behalf of the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control, has negotiated for urgent production of multivalent polysaccharide vaccines to be dispatched to Niger in the next few weeks. Vaccine campaigns targeting children aged 2--15 years are ongoing in most of the affected districts.

For more on **MERS in South Korea** see <http://www.promedmail.org/direct.php?id=3417452>For more on **anthrax in Turkey** see <http://www.promedmail.org/direct.php?id=3415967>For more on **meningitis in Niger** see <http://www.who.int/csr/don/15-may-2015-niger/en/>
